Skip to content

Biohaven BHVN Interest Paid

Interest Paid at other companies

uniQure logo
uniQureQURE
$6.72M+3.5%
Roivant Sciences logo
Roivant SciencesROIV
$0-100%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
Vera Therapeutics logo
Vera TherapeuticsVERA
$1.63M+3.2%
ADMA Biologics logo
ADMA BiologicsADMA
$1.33M-51.8%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$20.83M+15.1%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Biohaven’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's interest paid?
Biohaven (BHVN) reported interest paid of $54K in Q4 2025.
How has Biohaven's interest paid changed year-over-year?
Biohaven's interest paid increased by 72.8% year-over-year, from $31.25K to $54K.
What is the long-term trend for Biohaven's interest paid?
Over 4 years (2021 to 2025), Biohaven's interest paid has grown at a 19.2% compound annual growth rate (CAGR), from $107K to $216K.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.